MA39468A - Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave - Google Patents

Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave

Info

Publication number
MA39468A
MA39468A MA039468A MA39468A MA39468A MA 39468 A MA39468 A MA 39468A MA 039468 A MA039468 A MA 039468A MA 39468 A MA39468 A MA 39468A MA 39468 A MA39468 A MA 39468A
Authority
MA
Morocco
Prior art keywords
agave
addicts
nutritional
energy drinks
spirits
Prior art date
Application number
MA039468A
Other languages
English (en)
Other versions
MA39468B1 (fr
Inventor
Robert W Brocia
Original Assignee
Roar Holding Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roar Holding Llc filed Critical Roar Holding Llc
Publication of MA39468A publication Critical patent/MA39468A/fr
Publication of MA39468B1 publication Critical patent/MA39468B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12H—PASTEURISATION, STERILISATION, PRESERVATION, PURIFICATION, CLARIFICATION OR AGEING OF ALCOHOLIC BEVERAGES; METHODS FOR ALTERING THE ALCOHOL CONTENT OF FERMENTED SOLUTIONS OR ALCOHOLIC BEVERAGES
    • C12H3/00—Methods for reducing the alcohol content of fermented solutions or alcoholic beverage to obtain low alcohol or non-alcoholic beverages
    • C12H3/04—Methods for reducing the alcohol content of fermented solutions or alcoholic beverage to obtain low alcohol or non-alcoholic beverages using semi-permeable membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/02—Food
    • G01N33/14—Beverages
    • G01N33/146—Beverages containing alcohol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
    • G01N2333/90605—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4)
    • G01N2333/90633—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) in general
    • G01N2333/90638—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) in general with a definite EC number (1.4.3.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)

Abstract

L'invention concerne des compositions contenant des inhibiteurs de la monoamine oxydase préparées par élimination de l'alcool présent dans des boissons issues de l'agave.
MA39468A 2014-09-16 2015-09-16 Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave MA39468B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462071179P 2014-09-16 2014-09-16
US201562231592P 2015-07-10 2015-07-10
PCT/US2015/050509 WO2016044473A1 (fr) 2014-09-16 2015-09-16 Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave

Publications (2)

Publication Number Publication Date
MA39468A true MA39468A (fr) 2017-07-26
MA39468B1 MA39468B1 (fr) 2020-09-30

Family

ID=55453705

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39468A MA39468B1 (fr) 2014-09-16 2015-09-16 Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave

Country Status (25)

Country Link
US (3) US10195163B2 (fr)
EP (1) EP3194557B1 (fr)
JP (3) JP6687626B2 (fr)
KR (1) KR20170074863A (fr)
CN (1) CN107250340B (fr)
AU (3) AU2015317751B2 (fr)
BR (1) BR112017005328B1 (fr)
CA (1) CA2961608C (fr)
CY (1) CY1123421T1 (fr)
DK (1) DK3194557T3 (fr)
ES (1) ES2818097T3 (fr)
HK (1) HK1244834A1 (fr)
HR (1) HRP20201466T1 (fr)
HU (1) HUE051469T2 (fr)
LT (1) LT3194557T (fr)
MA (1) MA39468B1 (fr)
MX (1) MX2017003554A (fr)
NZ (1) NZ730510A (fr)
PL (1) PL3194557T3 (fr)
PT (1) PT3194557T (fr)
RS (1) RS60851B1 (fr)
RU (1) RU2742610C2 (fr)
SI (1) SI3194557T1 (fr)
WO (1) WO2016044473A1 (fr)
ZA (1) ZA201702165B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107250340B (zh) * 2014-09-16 2021-05-07 罗伯特·布洛西亚 源自基于龙舌兰的烈酒的能量饮品和其他营养辅助物
US10842841B2 (en) 2017-04-05 2020-11-24 Roar Holding Llc Method for isolation of MAO inhibitors from tequila or other distilled agave fermentation products
CN109370848B (zh) * 2018-11-05 2022-03-15 福建农林大学 一种红曲龙舌兰酒的加工方法
EP3886612A4 (fr) * 2018-11-26 2022-08-17 Roar Holding LLC Procédés d'amélioration de la qualité d'une boisson
US11839622B1 (en) 2020-01-15 2023-12-12 Randall Lewarchik Consumable nutraceutical composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6091997A (ja) * 1983-10-22 1985-05-23 Wako Pure Chem Ind Ltd モノアミンオキシダ−ゼ活性の測定方法
US4612196A (en) * 1984-08-23 1986-09-16 Miller Brewing Company Preparation of low alcohol beverages by reverse osmosis
US5262162A (en) 1991-09-06 1993-11-16 Merz & Co. Gmbh & Co. Cerebral-activating extract
US6506430B1 (en) * 1995-07-21 2003-01-14 Brown-Forman Corporation Oak aged alcoholic beverage extract and accelerated whisky maturation method
EP1083913A4 (fr) * 1998-06-05 2004-03-17 Regent Court Technologies Inhibiteurs de monoamine oxydase (mao) et leurs utilisations
JP4319735B2 (ja) * 1999-03-12 2009-08-26 丸善製薬株式会社 モノアミンオキシダーゼ阻害剤および飲食物
US20100178411A1 (en) 2009-01-13 2010-07-15 Alma Imports, Inc. Agave-plant-based composition of matter and methods of use
US8658236B2 (en) * 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
WO2011159967A1 (fr) 2010-06-18 2011-12-22 Butamax(Tm) Advanced Biofuels Llc Solvants d'extraction dérivés d'une huile pour l'élimination d'alcool dans une fermentation extractive
CA2783847C (fr) * 2012-07-24 2014-09-30 Luc Hobson Boisson ou produit alimentaire a teneur reduite en calorie et procede et appareil pour fabriquer celui-ci
US8609162B2 (en) * 2012-10-04 2013-12-17 Invivo Beverages Llc Integrated neuromodulation system for mood enhancement of a living human subject
CN107250340B (zh) * 2014-09-16 2021-05-07 罗伯特·布洛西亚 源自基于龙舌兰的烈酒的能量饮品和其他营养辅助物

Also Published As

Publication number Publication date
JP2020110180A (ja) 2020-07-27
AU2021232783B2 (en) 2024-05-09
NZ730510A (en) 2024-03-22
US10195163B2 (en) 2019-02-05
CN107250340A (zh) 2017-10-13
BR112017005328A2 (pt) 2017-12-12
HRP20201466T1 (hr) 2021-03-05
US20220047531A1 (en) 2022-02-17
AU2021232783A1 (en) 2021-10-14
WO2016044473A1 (fr) 2016-03-24
PT3194557T (pt) 2020-09-21
EP3194557B1 (fr) 2020-07-01
PL3194557T3 (pl) 2021-04-06
HUE051469T2 (hu) 2021-03-01
JP6687626B2 (ja) 2020-04-22
US20160074343A1 (en) 2016-03-17
US11160774B2 (en) 2021-11-02
AU2020200964A1 (en) 2020-02-27
RU2017112984A3 (fr) 2019-09-16
LT3194557T (lt) 2020-11-25
BR112017005328B1 (pt) 2021-11-16
RS60851B1 (sr) 2020-10-30
AU2015317751B2 (en) 2019-11-14
US20190231717A1 (en) 2019-08-01
ZA201702165B (en) 2018-04-25
HK1244834A1 (zh) 2018-08-17
CA2961608A1 (fr) 2016-03-24
CN107250340B (zh) 2021-05-07
RU2017112984A (ru) 2018-10-17
MX2017003554A (es) 2017-06-30
RU2742610C2 (ru) 2021-02-09
SI3194557T1 (sl) 2020-11-30
ES2818097T3 (es) 2021-04-09
KR20170074863A (ko) 2017-06-30
EP3194557A4 (fr) 2018-06-06
EP3194557A1 (fr) 2017-07-26
DK3194557T3 (da) 2020-09-21
MA39468B1 (fr) 2020-09-30
CA2961608C (fr) 2023-02-07
AU2015317751A1 (en) 2017-05-04
JP7212001B2 (ja) 2023-01-24
CY1123421T1 (el) 2021-12-31
JP2017529102A (ja) 2017-10-05
JP2023052345A (ja) 2023-04-11

Similar Documents

Publication Publication Date Title
CY1121360T1 (el) Αναστολεις dna-pk
EA201691794A1 (ru) Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
MA39468A (fr) Boissons énergisantes et autres adjuvants nutritionnels issus de spiritueux à base d'agave
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
EA202092987A2 (ru) Липид, содержащий докозапентаеновую кислоту
MX2021003792A (es) Inhibidores de benzoquinolina del transportador vesicular de monoaminas 2.
EA201790108A1 (ru) Гетероарильные соединения, пригодные в качестве ингибиторов sumo-активирующего фермента
EA201490826A1 (ru) Ингибиторы асс и их применения
EA201690022A1 (ru) Ингибиторы коррозии на основе органических дисульфидов
HRP20090213A2 (en) Process and intermediates for preparing integrase inhibitors
EA200971051A1 (ru) Ингибиторы p70 s6 киназы
AR084433A1 (es) Inhibidores de la faah y composiciones farmaceuticas que los contienen
EA201170295A1 (ru) ИНГИБИТОРЫ сМЕТ
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
EA201170508A1 (ru) Производные 1-амино-2-циклобутилэтилбороновой кислоты
AU2017317563A8 (en) Detergent compositions comprising xanthan lyase variants I
EA201070256A1 (ru) Способ и промежуточные соединения для получения ингибиторов интегразы
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
WO2018136437A3 (fr) Nouveaux composés utiles en tant qu'inhibteurs de l'indoléamine 2,3-dioxygénase et/ou du tryptophane dioxygénase
EA201490846A1 (ru) Новые производные арилхинолина
EA201490688A1 (ru) 2-тиопиримидиноны
WO2016079110A3 (fr) Utilisation d'enzymes pour le nettoyage
EA201990998A1 (ru) Фармацевтические составы и способы их получения